Trial | NCT04403334  Report issue

Title

Postoperative Safety Outcomes of Intraoperative Intracameral Preservative-Free Moxifloxacin Versus Levofloxacin
Postoperative Safety Outcomes in Patients Undergoing Routine Phacoemulsification Cataract Surgery With Intraoperative Intracameral Injection of Preservative-Free Moxifloxacin Versus Levofloxacin

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    114
Comparative safety study of intracameral levofloxacin versus moxifloxacin for postoperative infection prophylaxis
Randomized clinical trial comparing corneal and retinal changes after intracameral levofloxacin or moxifloxacin administered at the end of surgery among eyes undergoing uncomplicated phacoemulsification.
Study Started
Jan 02
2018
Primary Completion
Apr 28
2018
Study Completion
Apr 28
2018
Last Update
May 27
2020

Drug Levofloxacin Ophthalmic

0.1 ml of unpreserved 0.5% levofloxacin

Drug Moxifloxacin Ophthalmic

0.1 ml of unpreserved 0.5% moxifloxacin

Intracameral levofloxacin Experimental

0.5% unpreserved solution

Intracameral moxifloxacin Experimental

0.5% unpreserved solution

Criteria 

Inclusion Criteria:

Eyes undergoing uncomplicated cataract surgery by phacoemulsification

Exclusion Criteria:

Corneal opacities, corneal dystrophies, glaucoma, uveitis, retinopathy, optic neuropathy, concomitant infection (blepharitis, hordeolum, or conjunctivitis) or uncontrolled systemic disease and intraoperative complications that may affect visual outcomes were excluded from the study
No Results Posted